Panbela Therapeutics Inc
General ticker "PBLA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.6M
Panbela Therapeutics Inc does not follow the US Stock Market performance with the rate: -25.9%.
Estimated limits based on current volatility of 3.8%: low 0.31$, high 0.34$
Factors to consider:
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [10.90$, 33.49$]
- 2024-12-30 to 2025-12-30 estimated range: [6.83$, 19.46$]
Financial Metrics affecting the PBLA estimates:
- Negative: Non-GAAP EPS, $ of -669.09 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -99.99 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Interest expense per share, $ of 2916.52 > 0.74
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term PBLA quotes
Long-term PBLA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $10.01MM | $34.09MM | $51.29MM |
| Operating Income | $-10.01MM | $-34.09MM | $-51.29MM |
| Non-Operating Income | $-0.61MM | $-0.96MM | $25.84MM |
| Interest Expense | $0.01MM | $0.29MM | $0.32MM |
| R&D Expense | $5.42MM | $28.05MM | $20.61MM |
| Income(Loss) | $-10.62MM | $-35.05MM | $-25.45MM |
| Taxes | $-0.49MM | $-0.12MM | $-0.19MM |
| Profit(Loss) | $-10.13MM | $-34.93MM | $-25.26MM |
| Stockholders Equity | $10.21MM | $-8.05MM | $-4.71MM |
| Assets | $12.87MM | $4.98MM | $11.80MM |
| Operating Cash Flow | $-6.70MM | $-15.28MM | $-25.25MM |
| Capital expenditure | $0.00MM | $0.66MM | $0.00MM |
| Investing Cash Flow | $-0.54MM | $-0.66MM | $0.40MM |
| Financing Cash Flow | $10.10MM | $5.35MM | $26.14MM |
| Earnings Per Share* | $-20,773.70 | $-40,748.57 | $-232,429.55 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.